Prolonged cefazolin release from hydrogel-impregnated bone chips

To prevent infections after orthopedic surgery, intravenous antibiotics are administered perioperatively. Cefazolin is widely used as the prophylactic antibiotic of choice. Systemic antibiotic therapy may however be less effective in longstanding surgery where bone allografts are used. Bone chips have been shown to be an effective carrier for certain types of antibiotics. Bone allografts impregnated with antibiotics may therefore provide the necessary local antibiotic levels for prophylaxis. No prolonged release bone chip preparations have been described so far for cefazolin.  We developed a protocol to bind cefazolin in the porous structure of bone chips by means of a hydrogel composed of proteins naturally present in the human body.

 Three types of bone chips (fresh frozen, decellularized or lyophilized) were evaluated. Soaking of bone chips without hydrogel resulted in a quick release of cefazolin, which was limited to 4 hours. When vacuum was applied elution of >1 µg/ml cefazolin was measured for up to 36 hours. Combination with collagen hydrogel resulted in a higher cefazolin concentration released at 24 hours (3.9 vs 0.3 µg/ml), but not in a prolonged release. However, combination of decellularized frozen bone chips with fibrin hydrogel resulted in an initial release of 533 µg/ml followed by a gradual decline reaching the minimal inhibitory concentration at 72 hours (1.7 µg/ml), while not measurable anymore after 92 hours.

 

 Processed bone chips with hydrogel-cefazolin showed a markedly prolonged cefazolin release. When combined with a fibrin hydrogel, high initial peak levels of cefazolin were obtained, followed by a decreasing release over the following three days. This elution profile is desirable, since high initial levels are important to maximize anti-bacterial action whereas low levels of antibiotic for a limited time may stimulate osteogenesis. It is important that antibiotic release is ending after a few days as prolonged low levels of antibiotics are not clinically helpful and may lead to antibiotic resistance. Further preclinical studies are warranted to show effectiveness of hydrogel-cefazolin impregnated bone chips.

 

Authors

Duportail C (1)
Gerard M(1)
Buyse L(1)
Croes K (2)
Putzeys G (2)
Thorrez L (1)

Organisations

KU Leuven Kulak, Kortrijk, Belgium (1)
AZ Groeninge, Kortrijk, Belgium (2)

Presenting author

Lieven Thorrez, Professor, KU Leuven KULAK
lieven.thorrez@kuleuven.be
Contact us now
Register now

Flanders.bio Strategic Partners